Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: 5AM closes $285M fund

    5AM Ventures disclosed to BioCentury the firm closed its 5AM Ventures V fund at $285 million. The firm will continue to focus on early stage companies developing therapeutics, tools and drug delivery technologies. 5AM …

    Published on 5/27/2016
  • FINANCIAL NEWS: Aclaris raises $20M in private placement

    Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $20 million through the sale of 1.1 million shares at $18.50 in a private placement led by new investor Aisling Capital. Undisclosed new and existing investors also …

    Published on 5/27/2016
  • FINANCIAL NEWS: OvaScience sinks after follow-on

    OvaScience Inc. (NASDAQ:OVAS) fell $2.85 (29%) to $6.93 on Thursday after it raised $50.1 million through the sale of 7.2 million shares at $7 in a follow-on underwritten by Leerink Partners, Oppenheimer, H.C. …

    Published on 5/26/2016
  • FINANCIAL NEWS: Reata surges after IPO

    Reata Pharmaceuticals Inc. (NASDAQ:RETA) gained $2.07 (19%) to $13.07 in its first day of trading Thursday after it raised $60.5 million through the sale of 5.5 million shares at $11 in an IPO underwritten by Citigroup,…

    Published on 5/26/2016
  • FINANCIAL NEWS: Arrivo debuts with $49M

    Newco Arrivo BioVentures LLC (Research Triangle Park, N.C.) launched with a $49 million venture round led by Jazz Pharmaceuticals plc (NASDAQ:JAZZ). Solas BioVentures, Rex Health Ventures and undisclosed others also …

    Published on 5/25/2016
  • FINANCIAL NEWS: Coherus raises $63M in follow-on

    Coherus BioSciences Inc. (NASDAQ:CHRS) fell $1.38 to $18.12 on Monday after it raised $63 million through the sale of 3.5 million shares at $18 in a follow-on underwritten by Barclays. The company proposed and priced …

    Published on 5/23/2016
  • FINANCIAL NEWS: OrbiMed closes second Israel fund

    OrbiMed closed its OrbiMed Israel Partners II fund at $307 million. The firm plans to invest the new fund in 20 Israeli healthcare companies across all stages of development.OrbiMed opened an office in Israel in 2010, …

    Published on 5/23/2016
  • FINANCIAL NEWS: Japan pledges $130M to infectious disease fund

    The Japanese government will invest an additional $130 million in the The Global Heath Innovative Technology (GHIT) Fund, which supports R&D on infectious diseases including malaria, tuberculosis, HIV and neglected …

    Published on 5/20/2016
  • FINANCIAL NEWS: Merus inches up after IPO

    Bispecific antibody developer Merus B.V. (NASDAQ:MRUS) rose $0.04 to $10.04 in its first day of trading Thursday after it raised $55 million through the sale of 5.5 million shares at $10 in an IPO. Earlier this month, …

    Published on 5/19/2016
  • FINANCIAL NEWS: Repligen raises $100M in debt deal

    Bioprocessing company Repligen Corp. (NASDAQ:RGEN) raised $100 million in a senior convertible notes offering. The notes bear 2.125% interest, mature on June 1, 2021, and initially convert at $32.07, a 22% premium to …

    Published on 5/19/2016
  • FINANCIAL NEWS: WI Harper closes $175M fund

    WI Harper Group said it closed the oversubscribed WIH Fund VIII at $175 million. The firm focuses largely on the technology, media and telecommunications sector, but also invests in pharmaceutical discovery and …

    Published on 5/19/2016
  • FINANCIAL NEWS: Antiviral company Agenovir raises $10.6M

    Agenovir Corp. (South San Francisco, Calif.) raised $10.6 million in a series A round led by VC firm Data Collective. Celgene Corp. (NASDAQ:CELG), Lightspeed Venture Partners and individual investors also participated. …

    Published on 5/17/2016
  • FINANCIAL NEWS: Cancer vaccine play Nouscom raises EUR 12M

    Nouscom AG (Basel, Switzerland) raised EUR 12 million ($13.6 million) in a series A round co-led by LSP and Versant Ventures. Nouscom is developing Endovax, an antigenless vaccine based on oncolytic viruses; and Exovax,…

    Published on 5/17/2016
  • FINANCIAL NEWS: Maruyama to lead Astellas' VC arm

    The U.S.-based Astellas Venture Management investment arm of Astellas Pharma Inc. (Tokyo:4503) named Kazunori Maruyama executive investment director. He was the pharma's director of innovation management.Maruyama will …

    Published on 5/17/2016
  • FINANCIAL NEWS: BioSight raises $13M

    BioSight Ltd. (Karmiel, Israel) said it raised $13 million in a tranched venture financing co-led by Arkin Holdings and Primera Capital, each of which is to invest $5 million. Existing shareholders including Michael …

    Published on 5/16/2016
  • FINANCIAL NEWS: Caribou raises $30M series B

    CRISPR company Caribou Biosciences Inc. (Berkeley, Calif.) raised $30 million in a series B round. New investors Anterra Capital, Heritage Group, Maverick Capital and Pontifax AgTech joined existing investors F-Prime …

    Published on 5/16/2016
  • FINANCIAL NEWS: Biosimilar play Oncobiologics falls after IPO

    Oncobiologics Inc. (NASDAQ:ONSIU) dropped $1.20 (20%) to $4.80 in its first day of trading Friday after it raised a combined $40 million in an IPO and concurrent private placement. The company raised $35 million through…

    Published on 5/13/2016
  • FINANCIAL NEWS: Financial tracks

    Newly launched Taiho Ventures, the U.S.-based corporate VC arm of Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), named Sakae Asanuma president. Asanuma was president and CEO at Astellas Venture Management. Taiho is a …

    Published on 5/13/2016
  • FINANCIAL NEWS: Loxo raises $36M in follow-on

    Loxo Oncology Inc. (NASDAQ:LOXO) raised $36 million through the sale of 1.7 million shares at $21.50 in a follow-on underwritten by Citigroup, Cowen and Stifel. Loxo proposed the offering after market hours Wednesday, …

    Published on 5/12/2016
  • FINANCIAL NEWS: G1 raises $47M in C round

    G1 Therapeutics Inc. (Research Triangle Park, N.C.) raised $47 million in an untranched series C round led by new investor Cormorant Asset Management.New investors including Aju IB Investment, Cowen Private Investments,…

    Published on 5/11/2016
  • FINANCIAL NEWS: Knight raises C$200M in bought deal

    Knight Therapeutics Inc. (TSX:GUD) raised C$200 million ($154.5 million) through the sale of 25 million shares at C$8 to a syndicate of underwriters led by GMP Securities in a bought deal.The company focuses on …

    Published on 5/11/2016
  • FINANCIAL NEWS: Longitude targeting $525M for third fund

    Life science venture firm Longitude Capital has set a $525 million target for its third fund, Longitude Venture Partners III, according to an SEC filing. The firm declined to comment.Longitude closed its second fund in …

    Published on 5/11/2016
  • FINANCIAL NEWS: Novimmune raises CHF30M

    Novimmune S.A. (Plan-les-Ouates, Switzerland) raised CHF30 million ($30.9 million) in a venture round from existing investors. It raised a separate CHF30 million round in January from insiders. The company did not …

    Published on 5/11/2016
  • FINANCIAL NEWS: Oxford spinout OxStem raises L16.9M

    University of Oxford spinout OxStem Ltd. (Oxford, U.K.) raised L16.9 million ($24.3 million) in a venture round to develop small molecules designed to program adult stem and stem-like cells in situ to induce repair or …

    Published on 5/10/2016
  • FINANCIAL NEWS: Taiho launches strategic VC arm

    Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan) launched Taiho Ventures, a strategic investment arm headquartered in California, with $50 million. The firm intends to invest in cancer start-ups globally, with a focus on …

    Published on 5/10/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993